The expression levels of PHLPP1 and PHLPP2 and p-Akt (S473) and p-Erk1/2 (Figure 1) in lung adenocarcinoma were assessed by immunohistochemistry. This evidence concerns the gene MAPK3 and lung adenocarcinoma.